FDA — authorised 12 December 2005
- Marketing authorisation holder: INSMED
- Status: approved
FDA authorised MECASERMIN RINFABATE on 12 December 2005
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 12 December 2005.
INSMED holds the US marketing authorisation.